<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The pathophysiology of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> is well studied in small-animal models, which offer reproducibility and control of confounding variables-factors essential to hypothesis-testing </plain></SENT>
<SENT sid="1" pm="."><plain>This presentation first highlights insights into the ischemic penumbra enabled by a multimodal experimental approach; second, discusses gene expression in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>; and third, confronts the challenges of neuroprotectant therapy </plain></SENT>
<SENT sid="2" pm="."><plain>SUMMARY OF REVIEW: The ischemic penumbra: Transient (2-hour) middle cerebral artery suture-occlusion in anesthetized rats gives rise to highly consistent neurological and histopathological sequelae </plain></SENT>
<SENT sid="3" pm="."><plain>Autoradiographic local cerebral blood flow (LCBF) studies at 2 hours of occlusion define the penumbra as a region of intermediate CBF <z:hpo ids='HP_0000716'>depression</z:hpo> (20% to 40% of control) surrounding the densely ischemic core (5% to 20% of control) and constituting one half of the entire lesion </plain></SENT>
<SENT sid="4" pm="."><plain>Local <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolic rate in the <z:hpo ids='HP_0011009'>acute</z:hpo> penumbra is not reduced despite the critical CBF reduction, so that the penumbral metabolism/blood flow ratio is markedly elevated </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, following 1 hour of recirculation, <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism throughout the previously ischemic hemisphere has become markedly depressed, and the metabolism/flow ratio has pseudonormalized </plain></SENT>
<SENT sid="6" pm="."><plain>By correlating these data with histopathology using multimodal image analysis, the probability of infarction is shown to be highly determined by the degree of antecedent CBF reduction </plain></SENT>
<SENT sid="7" pm="."><plain>These animal data agree strikingly with published results in patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> studied by <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography </plain></SENT>
<SENT sid="8" pm="."><plain>This remarkable correspondence belies the assertion that data from lower species may not be relevant to human <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Gene expression: Perfusion gradients also determine differential patterns of gene expression in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>This can be demonstrated by correlating in situ hybridization autoradiographs for gene expression with autoradiographic LCBF data and histological <z:mpath ids='MPATH_124'>infarct</z:mpath> maps derived from replicate series </plain></SENT>
<SENT sid="11" pm="."><plain>In other studies, DNA microarray technology is used to screen for thousands of expressed genes </plain></SENT>
<SENT sid="12" pm="."><plain>In the 2-hour middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model with 3-hour recirculation, we have identified 28 known <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-<z:mp ids='MP_0005039'>hypoxia</z:mp> response genes that are upregulated and 6 that are downregulated, together with 35 upregulated and 41 downregulated genes newly connected with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>These findings underscore the enormous complexity of ischemic biology and suggest possible novel mechanisms for future exploration </plain></SENT>
<SENT sid="14" pm="."><plain>NEUROPROTECTION: A desirable neuroprotectant would, in theory, antagonize multiple injury mechanisms </plain></SENT>
<SENT sid="15" pm="."><plain>We have explored 2 such therapies of particular promise </plain></SENT>
<SENT sid="16" pm="."><plain>Mild brain <z:hpo ids='HP_0002045'>hypothermia</z:hpo> (32 degrees C target temperature, for 5 hours) is highly neuroprotective even when initiated at the <z:hpo ids='HP_0003674'>onset</z:hpo> of recirculation </plain></SENT>
<SENT sid="17" pm="."><plain>Another highly <z:chebi fb="1" ids="50267">protective agent</z:chebi> is human albumin, administered in doses of 1.25 to 2.5 g/kg--a therapy that reduces <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in this <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> model by 60% to 65%, markedly diminishes <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e>, and has a therapeutic window extending to 4 hours </plain></SENT>
<SENT sid="18" pm="."><plain>CONCLUSION: The careful study of rodent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> models can yield valuable, clinically relevant insights into the pathophysiology of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>